Correlation Between CBrain AS and Ascelia Pharma

Can any of the company-specific risk be diversified away by investing in both CBrain AS and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CBrain AS and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between cBrain AS and Ascelia Pharma AB, you can compare the effects of market volatilities on CBrain AS and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CBrain AS with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CBrain AS and Ascelia Pharma.

Diversification Opportunities for CBrain AS and Ascelia Pharma

-0.33

Correlation Coefficient

CBrain AS  Ascelia Pharma

Very good diversification

The 3 months correlation between CBrain and Ascelia is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding cBrain AS and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and CBrain AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cBrain AS are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of CBrain AS i.e., CBrain AS and Ascelia Pharma go up and down completely randomly.

Pair Corralation between CBrain AS and Ascelia Pharma

Assuming the 90 days trading horizon cBrain AS is expected to under-perform the Ascelia Pharma. In addition to that, CBrain AS is 1.32 times more volatile than Ascelia Pharma AB. It trades about -0.01 of its total potential returns per unit of risk. Ascelia Pharma AB is currently generating about 0.02 per unit of volatility. If you would invest  292.00  in Ascelia Pharma AB on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Ascelia Pharma AB or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

cBrain AS  vs.  Ascelia Pharma AB

cBrain AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days cBrain AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CBrain AS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Ascelia Pharma AB

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Ascelia Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with CBrain AS and Ascelia Pharma

The main advantage of trading using opposite CBrain AS and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CBrain AS position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.

The idea behind cBrain AS and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.